The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Case Studies
CHRISTUS Santa Rosa Improves Quality and Efficiency of Lab Test Procedures for Lower Costs and Enhanced Patient Care Delivery
This is an executive summary of the case study published in the
Case Studies
Kaiser Permanente Improves Patient Care Experience While Saving $10M and Avoiding 4,522 Hospital Patient Days through Back Brace Program
This is an executive summary of the case study published in the
Case Studies
Avera’s Centralized and Streamlined Logistics Network Improves Care Quality and Supports System-Wide Growth without Increasing Costs
This is an executive summary of the case study published in the
Case Studies
Mercy ROi Drives Value Across Care Pathways by Capturing the True Cost and Utilization of Products and Services
This is an executive summary of the case study published in the
Case Studies
Northwell Health Reduces C. difficile Rates by 41% Through Process and Product Standardization
This is an executive summary of the case study published in the
Case Studies
CQO Movement Case Study: Procurement of Blood Products
Overview